Internalizing RGD (iRGD)-modified liposomal nanoparticles as a universal antigen-delivering platform for remodeling tumors and enhancing T-cell receptor-engineered T cell immunotherapy
Internalizing RGD (iRGD)-modified liposomal nanoparticles as a universal antigen-delivering platform for remodeling tumors and enhancing T-cell receptor-engineered T cell immunotherapy. // Colloids and Surfaces B: Biointerfaces. – URL: https://www.sciencedirect.com/science/article/pii/S0927776526008544?dgcid=rss_sd_all
Internalizing RGD (iRGD)-modified liposomal nanoparticles as a universal antigen-delivering platform for remodeling tumors and enhancing T-cell receptor-engineered T cell immunotherapy. Colloids and Surfaces B: Biointerfaces. https://www.sciencedirect.com/science/article/pii/S0927776526008544?dgcid=rss_sd_all
“Internalizing RGD (iRGD)-modified liposomal nanoparticles as a universal antigen-delivering platform for remodeling tumors and enhancing T-cell receptor-engineered T cell immunotherapy.” Colloids and Surfaces B: Biointerfaces.
@article{article8284,
title = {Internalizing RGD (iRGD)-modified liposomal nanoparticles as a universal antigen-delivering platform for remodeling tumors and enhancing T-cell receptor-engineered T cell immunotherapy},
journal = {Colloids and Surfaces B: Biointerfaces},
url = {https://www.sciencedirect.com/science/article/pii/S0927776526008544?dgcid=rss_sd_all}
}